340B PATIENTS Act of 2025

This bill aims to keep discounted prescription drugs available to patients served by safety-net hospitals, clinics, and health centers. It says drug makers must offer 340B discount prices no matter where the drug is dispensed, including through outside “contract pharmacies” such as specialty or mail-order pharmacies that many patients rely on . It also blocks drug makers from adding extra hurdles—like limiting where drugs can be shipped or dispensed, or forcing clinics to hand over claims data—unless the Health and Human Services Secretary approves those conditions in advance . The findings explain that these savings help providers stretch resources and serve more people, and that contract pharmacies are often the only way to get certain specialty medicines to patients .

To enforce this, the bill creates strong fines for drug makers that intentionally violate these rules, up to $2,000,000 per day, with details to be set by regulation within 180 days. Clinics will also get a formal process to file claims when they believe manufacturers broke the rules, which must be set up within 180 days .

• Who is affected: Patients who use safety-net providers; hospitals, clinics, and health centers in the 340B program; drug manufacturers; and contract pharmacies .
• What changes: Manufacturers must honor discounts regardless of where drugs are dispensed; they cannot add new conditions without approval; the same protections apply when clinics use contract pharmacies; and there are new penalties for violations .
• When: The Secretary must issue enforcement and claims-process rules within 180 days of enactment; penalties apply to intentional violations once rules are in place .